LCTX icon

Lineage Cell Therapeutics
LCTX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5.5
222% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
71% 1-yr LCTX win rate
25 Nov ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Joseph Pantginis
60% 1-yr LCTX win rate
24 Nov ‘25 1 month ago